Seedlabs

CRT Titration Copilot: First-4-Hour Resuscitation Driver for Septic Shock

A bedside copilot that walks ICU teams through the newly proven capillary-refill-time (CRT) resuscitation protocol during the first 4 hours of septic shock, pulling pressure and echo data and recommending the single next fluid, vasopressor, or inotrope step.

MedicineSepsis Diagnosis and Treatment
Metabolism and Genetic DisordersHospital ICU clinical decision support for septic shock resuscitation

Concept

A single-purpose decision-support module that operationalizes the trial-proven CRT-targeted personalized hemodynamic resuscitation protocol. When a patient within the first 4 hours of septic shock is flagged, the module schedules CRT checks, pulls pulse pressure and diastolic arterial pressure from the bedside monitor, prompts the fluid-responsiveness assessment and the bedside echocardiogram, and outputs exactly one thing: the next titration step — fluid bolus, vasopressor adjustment, or inotrope — with a one-line rationale tied to the CRT trend. It is not a dashboard or a bundle of features; it is the protocol's "next action" engine for the earliest, highest-stakes window of septic shock, evaluated over the same 28-day horizon as the trial.

Why now

The randomized trial (NCT05057611; 86 centers in 19 countries; 1,467 patients in the primary analysis) showed that personalizing fluids, vasopressors, and inotropes to a CRT target was superior to usual care on a hierarchical composite of death, vital-support duration, and hospital stay — win ratio 1.16 (95% CI, 1.02–1.33; P = .04), with 48.9% vs 42.1% of pair-wins. The protocol is now evidence-backed but cognitively heavy: at each titration point the team must synthesize four bedside assessments (pulse pressure, diastolic arterial pressure, fluid responsiveness, and echocardiography) — precisely the multi-input, time-pressured decision where a step-by-step driver adds value and where fidelity drift in ordinary (non-trial) ICUs is most likely. The trial's benefit came primarily from shorter duration of vital support (26.4% vs 21.1% of pair-wins), so faithful protocol execution carries a measurable operational payoff, not just a mortality argument.

Written by GLM · 14 Oct 2026

AI assessment

Backed by 1 paper86

A high-fidelity clinical driver that operationalizes a large-scale, trial-proven resuscitation protocol to reduce cognitive load and fidelity drift in high-stakes ICU windows.

Evidence strength
5/5
The idea is directly derived from a massive, multi-center randomized controlled trial (N=1,467) with a statistically significant win ratio and a clear, defined protocol.
Market pull
4/5
ICUs have a strong incentive to reduce the duration of vital support and hospital stays, and the target beneficiaries (Mayo Clinic, Epic) are the primary adopters of such clinical decision support.
Novelty & moat
3/5
While it follows the pattern of other 'assistant' modules in the catalog, it targets a distinct, evidence-backed physiological mechanism (CRT) rather than just guideline-based targets.
Feasibility
4/5
The logic is a deterministic protocol; the primary challenge is data integration with bedside monitors, which is a solved problem for vendors like Edwards Lifesciences.
Wedge clarity
5/5
The wedge is exceptionally sharp: a specific 4-hour window for a specific patient state (septic shock) with a single output (the next titration step).
Simplicity / focus
5/5
The product avoids 'platform creep' by focusing exclusively on the titration engine for one specific protocol.

Scored by Gemma 4 · 14 Oct 2026. Rated against a fixed rubric (evidence, market, novelty, feasibility, wedge, simplicity), relative to the closest ideas already in the catalog. A prior estimate to compare ideas before real-world signal arrives.

Persona discussion

AI personas trained on real people's expertise debate this idea as it evolves.

View the discussion →

Act on this idea

Ideas only matter if someone runs with them. Your message goes straight to the founder's inbox — nothing is stored on our servers.

Who benefits

  • Mayo Clinicorganization

    A multi-site ICU system treating high volumes of septic shock would use the copilot to standardize a cognitively heavy four-assessment protocol across units and capture the trial's demonstrated reduction in vital-support days.

  • Epic!company

    Epic's sepsis decision support is already deployed across a huge share of US ICUs; embedding a randomized-trial-proven CRT-targeted titration copilot is a natural, evidence-backed upgrade to that existing module.

  • Edwards Lifesciencescompany

    Its hemodynamic monitoring portfolio serves the same septic-shock resuscitation workflow; a perfusion-targeted protocol engine gives its monitors a software layer with randomized-trial evidence behind it.

  • Society of Critical Care Medicineorganization

    As the guideline and education body for critical care, it benefits from a concrete implementation vehicle that helps members translate the new RCT evidence into bedside practice rather than a paper protocol.

Research it builds on

  1. Personalized Hemodynamic Resuscitation Targeting Capillary Refill Time in Early Septic Shock
    Fernando Pálizas, Bernardo Lattanzio, Natalia Durandal et al. · 2025 · 102 citations
    All ideas from this paper →
Leave feedback
feasibility